Following a share price correction, Maybank Kim Eng Research analyst Lai Gene Lih has upgraded Raffles Medical Group to “buy” on improved risk-reward. Lai’s target price on the medical services provider, however, remains unchanged at 99 cents.
“RMG’s key sustainability factor is ensuring patient safety and regulatory compliance. Raffles Hospital Singapore (RHS) is also JCI accredited since 2008, underscoring its commitment to patient safety and quality healthcare. RMG also places strong emphasis on employee welfare and diversity. Key risk is slower than expected recovery of foreign patient volumes,” writes Lai in a report dated Sept 30.
